Abstract
Background
Complement factor H (CFH) polymorphism Y402H has been shown to be significantly associated with age-related macular degeneration (AMD). Furthermore, histopathological studies in AMD have implicated basal laminar deposits (BLD) in the development of choroidal neovascularization (CNV) membranes. The purpose of this study was to correlate CFH staining in BLD with the CFH genotype at the tyrosine 402 histidine (Y402H) polymorphism.
Patients and methods
During macular translocation, 21 angiographically confirmed CNV membranes were extracted in 21 patients. The specimens were analysed histologically for BLD. The presence of CFH, complement proteins, and vitronectin was determined by immunohistochemistry. Finally, the CFH Y402H genotype was established by direct sequencing analysis.
Results
Histological examination demonstrated BLD in all of the excised CNV membranes. By immunostaining CFH was detected in the peripheral aspect at the inner and outer surface of BLD, which colocalized with other proteins of the complement cascade (C3, C5b-9). Similarly, vitronectin was detected in all of the BLD investigated. Four patients were noncarriers of CFH Y402H polymorphism, nine patients were heterozygous and eight patients homozygous for the CFH Y402H polymorphism.
Conclusions
BLD are composed of different complement factors (factor H, C3, C5b-9) and extracellular matrix proteins such as vitronectin. The prevalence of homozygous carriers in regard to CFH Y402H polymorphism, which is suspicious for AMD, might be associated with increased secretion of vitronectin in response to dysregulation of the complement cascade.
Similar content being viewed by others
References
Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134(3):411–431
de Boer HC, Preissner KT, Bouma BN, de Groot PG (1992) Binding of vitronectin-thrombin-antithrombin III complex to human endothel cells is mediated by the heparin binding site of vitronectin. J Biol Chem 267:2264–2268
Bressler NM, Bressler SB, Gragoudas ES (1987) Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol 105(2):209–213
Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421–424
Grossniklaus HE, Gass JDM (1998) Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalomol 126(1):59–69
Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102(20):7227–7232
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308(5720):419–421
Hermans P, Lommatzsch A, Bornfeld N, Pauleikhoff D (2003) Angiographic-histological correlation of late exudative age-related macular degeneration. Ophthalmologe 100:378–383
Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308(5720):385–389
Lafaut BA, Bartz-Schmidt KU, Vanden Broecke C, Aisenbrey S, De Laey JJ, Heimann K (2000) Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol 84:239–243
Macular Photocoagulation Study Group (1991) Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 109(9):1242–1257
Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y et al (2006) CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 3(1):e5
Pauleikhoff D, Löffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240(7):533–538
Podack ER, Muller-Eberhard HJ (1979) Isolation of human S-protein and inhibitor of the membrane attack complex of complement. J Biol Chem 254:9908–9914
Postel EA, Agarwal A, Caldwell J, Gallins P, Toth C, Schmidt S et al (2006) Complement factor H increase risk for atrophic age-related macular degeneration. Ophthalmology 113(9):1504–1507
Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14(21):3227–3236
Sarks SH (1976) Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 60(5):324–341
Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, Ott J et al (2005) Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77(1):149–153
Acknowledgements
The study was supported by the German Research Foundation (DFG Pa357/5-2).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lommatzsch, A., Hermans, P., Weber, B. et al. Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245, 1713–1716 (2007). https://doi.org/10.1007/s00417-007-0649-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0649-7